World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
30945
World Ranking
16936
National Ranking
8495

Overview

Steven T. Rosen is affiliated with the City Of Hope National Medical Center in the United States. Their research spans significant areas within medicine and biochemistry, genetics, and molecular biology, with a focus on oncology, molecular biology, pathology, forensic medicine, immunology, and dermatology.

The scientist's work addresses several key topics, including:

  • Lymphoma Diagnosis and Treatment
  • Cutaneous lymphoproliferative disorders research
  • CAR-T cell therapy research
  • Chronic Lymphocytic Leukemia Research
  • RNA modifications and cancer
  • Multiple Myeloma Research and Treatments
  • Immune Cell Function and Interaction

Recent publications authored or co-authored by Steven T. Rosen include:

  • "The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee," 2022, Blood
  • "Enabling Technologies for Personalized and Precision Medicine," 2020, Trends in biotechnology
  • "METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis," 2022, Nature Cell Biology
  • "Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE," 2022, Blood
  • "TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal," 2023, Cell stem cell

The scientist frequently publishes in the following venues:

  • Blood
  • Cancer Research
  • Neuromodulation Technology at the Neural Interface
  • Current Opinion in Oncology
  • Clinical Lymphoma Myeloma & Leukemia

Steven T. Rosen collaborates frequently with other researchers, including:

  • Christiane Querfeld
  • Jasmine Zain
  • Stephen J. Forman
  • Alex F. Herrera
  • Larry W. Kwak

Best Publications

  • Revised response criteria for malignant lymphoma

    Bruce D. Cheson;Beate Pfistner;Malik E. Juweid;Randy D. Gascoyne

  • An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

    Lauren Averett Byers;Lixia Diao;Jing Wang;Pierre Saintigny

  • Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.

    Kenneth R. Carson;Andrew M. Evens;Elizabeth A. Richey;Thomas M. Habermann

  • T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus

    Masahiro Shuda;Huichen Feng;Hyun Jin Kwun;Steven T. Rosen

  • Multiplexed detection of protein cancer markers with biobarcoded nanoparticle probes.

    Savka I. Stoeva;Jae Seung Lee;Jennifer E. Smith;Steven T. Rosen

  • European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.

    Nancy J. Senff;Evert M. Noordijk;Youn H. Kim;Martine Bagot

  • Enabling Technologies for Personalized and Precision Medicine

    Dean Ho;Stephen R. Quake;Edward R.B. McCabe;Wee Joo Chng;Wee Joo Chng

  • Peripheral T-cell lymphoma

    Francine M. Foss;Pier Luigi Zinzani;Julie M. Vose;Randy D. Gascoyne

  • Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study

    John F Seymour;John F Seymour;Shuo Ma;Danielle M Brander;Michael Y Choi

  • Mechanisms of Glucocorticoid-mediated Apoptosis in Hematological Malignancies

    Stephanie Greenstein;Kulsoom Ghias;Nancy L. Krett;Steven T. Rosen

  • Primary Cutaneous B-Cell Lymphoma: Review and Current Concepts

    Tomi L. Pandolfino;Richard S. Siegel;Timothy M. Kuzel;Steven T. Rosen

  • Treatment of mycosis fungoides with photochemotherapy (PUVA): Long-term follow-up

    James J Herrmann;Henry H Roenigk;Arti Hurria;Timothy M Kuzel

  • Interferon alfa-2a in the treatment of cutaneous T cell lymphoma.

    Elise A. Olsen;Steven T. Rosen;Robin T. Vollmer;Daina Variakojis

  • Apaf-1/Cytochrome c-independent and Smac-dependent Induction of Apoptosis in Multiple Myeloma (MM) Cells

    Dharminder Chauhan;Teru Hideshima;Steven Rosen;John C. Reed

  • Folliculotropic Mycosis Fungoides: An Aggressive Variant of Cutaneous T-Cell Lymphoma

    Pedram Gerami;Steve Rosen;Timothy Kuzel;Susan L. Boone

  • T-cell non-Hodgkin lymphoma

    Mujahid A. Rizvi;Andrew M. Evens;Martin S. Tallman;Beverly P. Nelson

  • Cytochrome c-dependent and -independent Induction of Apoptosis in Multiple Myeloma Cells

    Dharminder Chauhan;Pramod Pandey;Atshushi Ogata;Gerrard Teoh

  • Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study.

    S T Rosen;A M Zimmer;R Goldman-Leikin;L I Gordon

  • SHP2 Mediates the Protective Effect of Interleukin-6 against Dexamethasone-induced Apoptosis in Multiple Myeloma Cells *

    Dharminder Chauhan;Pramod Pandey;Teru Hideshima;Steven Treon

  • Peripheral T‐Cell Lymphoma

    Kevin C. Gatter;Georges Delsol;Roger A. Warnke;Francesco Pezzella

Frequent Co-Authors

Timothy M. Kuzel
Timothy M. Kuzel Rush University Medical Center
Leo I. Gordon
Leo I. Gordon Northwestern University
Alfred W. Rademaker
Alfred W. Rademaker Northwestern University
Varsha Gandhi
Varsha Gandhi The University of Texas MD Anderson Cancer Center
Martin S. Tallman
Martin S. Tallman Northwestern University
William J. Gradishar
William J. Gradishar Northwestern University
John D. Minna
John D. Minna The University of Texas Southwestern Medical Center
Paul A. Bunn
Paul A. Bunn University of Colorado Boulder
Susan L. Cohn
Susan L. Cohn University of Chicago
Massimo Federico
Massimo Federico University of Modena and Reggio Emilia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn't always follow the traditional path. Online degrees now offer flexible options for students seeking entry into healthcare roles or aiming to advance their careers. For those interested in becoming registered nurses, there are cheap online nursing programs that make it easier and more affordable to begin your journey.

Many RNs look to build on their credentials with a Bachelor of Science in Nursing. The cheapest rn to bsn online programs are a popular option for working professionals who need flexibility. If you’re aspiring to leadership or advanced clinical roles, consider the cheapest dnp online program to pursue doctoral-level education without breaking the bank.

Finally, if you hold a non-nursing bachelor’s degree but want to shift into nursing, several schools offer online direct entry msn programs. These degrees can fast-track your transition into nursing, opening doors to new opportunities across the healthcare sector.

Best Scientists Citing Steven T. Rosen

Trending Scientists